Metformin Improves Outcomes in HER2+ Breast Cancer Patients With Diabetes

Treatment with metformin may improve outcomes in patients with HER2 –positive primary breast cancer and diabetes, according to an analysis of the phase III ALTTO trial.

Source: CancerNetwork - May 16, 2017 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer HER2-Positive Breast Cancer News Source Type: news